Clinical Trial

CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPICAL FORMULA ON DEPIGMENTATION OF LENTIGO SPOTS

Study acronym: EPILADY
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 20, 2025 (before its estimated May 8, 2026 completion). Its status may not reflect the trial's current state.
Summary
To assess the efficacy of the Epilady investigational device, used with and without a topical depigmenting formula, in reducing the appearance of lentigo spots on the hands and forearms of healthy female participants over an 84-day period
Trial Details
NCT Number NCT07239726
Lead Sponsor Cosmetique Active International
Conditions Solar Lentigo
Enrollment 44 participants
Start Date 2026-01-07
Primary Completion 2026-05-08 (estimated)
Study Completion 2026-05-08 (estimated)
Updated on ClinicalTrials.gov 2025-11-20